Cargando…
Recent developments in immunotherapy of cancers caused by human papillomaviruses
A subset of oncogenic human papillomaviruses (HPVs) is the main cause of genital cancers, most importantly cervical cancer and an increasing number of head and neck cancers. Despite the availability of prophylactic vaccines against the most prevalent oncogenic HPV types, HPV‐induced malignancies are...
Autores principales: | Fakhr, Elham, Modic, Živa, Cid‐Arregui, Angel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044335/ https://www.ncbi.nlm.nih.gov/pubmed/33205441 http://dx.doi.org/10.1111/imm.13285 |
Ejemplares similares
-
Therapeutic Vaccines Against Human Papillomavirus and Cervical Cancer
por: Cid-Arregui, Angel
Publicado: (2009) -
TCR-like CARs and TCR-CARs targeting neoepitopes: an emerging potential
por: Poorebrahim, Mansour, et al.
Publicado: (2021) -
Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals
por: Quiros-Fernandez, Isaac, et al.
Publicado: (2021) -
ONCOGENIC HUMAN PAPILLOMAVIRUSES: High-Risk Human Papillomaviruses: Towards a Better Understanding of the Mechanisms of Viral Transformation, Latency and Immune-Escape
por: Cid Arregui, A, et al.
Publicado: (2012) -
Recent Developments in Human Papillomavirus (HPV) Vaccinology
por: Williamson, Anna-Lise
Publicado: (2023)